Do not buy? Stryker statement: There is no discussion of the acquisition of Poco

Pharma News, June 15. US time, June 13, Stryker issued a statement, it did not discuss potential acquisitions with Boston Scientific.

In the statement, Stryker stated that 'Stryker is not in discussions with Boston Scientific Corporation regarding a potential acquisition'.

After the statement was issued, Stryker's stock price rose by 2.5%. In the past two days, due to acquisition rumors, its stock price has dropped by 9.2%. Boston Scientific's stock price has dropped by 6.3%. In the past two days, its stock price Has risen 6%.

United States medical instruments The growth of the industry has slowed down and it is more difficult to grow. In the face of industry and regulatory changes, lower demand for medical costs, and pressure from investors, large companies have sought to scale up and diversify their products to reduce overlapping costs.

As far as Stryker's statement is concerned, it is said that 'there is no discussion'. As for whether or not it has been discussed before, whether or not the acquisition of Boston Science will be discussed in the future, Stryker did not explicitly reply.